(MMed(Urol) (Medunsa), FCUrol(SA))

Prof. Shingai Mutambirwa holds MMed (Urology) Medunsa and FCS (Urol) degrees qualifying in 1996.

Head of Department of Urology at Dr George Mukhari Academic hospital and Sefako Makgatho Health Sciences University in Pretoria, South Africa since 2008 to date, where he teaches post and undergraduate students. In addition he has published over 80 peer reviews articles and 10 book chapters, and is heavily involved in a number of industry driven and university research projects...

Memberships of professional societies:

• Founding member of the Prostate Cancer Foundation of South Africa
• Current head of the academic committee for South African Urological Association (SAUA)
• Head of Review Board for "South African Guidelines for Prostate Cancer” coordinating the multi-disciplinary team for all the South African societies forOncologists ,Urologists, Nuclear Medicine and Pathogists involved in this cancer.
• Head of Review Board for "South African Guidelines for Enuresis” under the Enuresis Academy of South African
• Academic committee chair for the Urological Colleges of Medicine of South Africa (CMSA).
• Academic committee member for the African Society of Sexual Medicine (ASSM).
• Member of Continence Association of South Africa (CASA)
• Amongst others

Peer Reviewer for:

• The Journal of Urology (Official journal of the American Urological Association)
• The African Journal of Urology
• Hindawi online publications

Board Membership:

• The Prostate Cancer Foundation of South Africa (Founding member)
• Senator (Urology) for the Colleges of Medicine of South Africa (CMSA)

Dr. Jill Karen Harris is a Clinical and Radiation Oncologist practicing at Cancercare’s Constantiaberg Oncology Unit within Mediclinic Constantiaberg in Cape Town, South Africa.

She earned her MBChB from the University of Cape Town in 1991 and completed her FC Rad Onc (SA) through the Colleges of Medicine in 1998. Dr. Harris has a particular interest in planning and radiotherapy techniques, focusing much of her clinical work on prostate and breast cancer patients.

She emphasizes integrated cancer care, advocating for centralized, patient-friendly environments to enhance treatment efficiency and comfort. Beyond clinical practice, Dr. Harris is involved in patient education and advocacy, addressing aspects of cancer survivorship such as managing treatment costs, coping with recurrence fears, and combating fatigue

Dr Chantelle Scott is an HPCSA-registered genetic counsellor who runs a private practice at Panorama Mediclinic in Cape Town. She holds a BSc in Biological Human Life Sciences (Stell), a BSc Hons in Genetics (Stell), an MSc Med in Genetic Counselling (UCT), and a PhD in Human Genetics (Stell).

With over 14 years of experience, including a year spent working in the UK, Dr Scott specialises in the interpretation of genetic test results, personalised risk assessment, and supporting informed decision-making. She also provides comprehensive psychosocial support to individuals and families navigating genetic conditions.

Since 2011, she has actively contributed to research across several departments within the Faculty of Medicine and Health Sciences at Stellenbosch University, including Human Genetics, Obstetrics and Gynaecology, Medical Ethics and Law and Urology. Her primary research interests lie in prenatal genetics and oncology.

As a passionate advocate for advancing genetic healthcare, Dr Scott is committed to patient education and empowerment and currently serves on the Medical Advisory Board of the Prostate Cancer Foundation of South Africa and is actively involved with the Down Syndrome Association Western Cape.

(BSc(Hons, MBChB (University of Wits), FCUrol(SA), MMed(Urol) (UKZN))

Dr Ronald James Urry, received his first BSc(Hons) in human genetics in 2001, followed by an MBBCh in 2004. He completed his fellowship in urology and achieved the FCUrol(SA) examinations in 2013. Throughout his training, Dr Urry became enamoured with research. Presently he has several peer reviewed papers and congress presentations to his name, and some currently in the press.

Dr Urry spent 18 months as the acting head of department where he supervised clinical work, trained registrars clinically and academically with a number of registrars completing their fellowships under his guidance, and supervised research projects.

At the end of 2015, James embarked on a 6-month fellowships in laparoscopic and robotic surgery and ventured deeper into laparoscopic surgery, robotic and uro-oncology at the East Sussex University in the United Kingdom. Dr Urry has since moved back to Johannesburg and in addition to establishing his own private practice, the Johannesburg Academic Urology Centre (JAUC) he is currently serving as the secretary of the South African Urological Association (SAUA).

(MBChB (Medunsa), PhD (Ghent, Belgium) FAMS (Singapore Academy of Medicine), Hon FCMSA (SA), Elected Member of the Academy of Science of South Africa (MASSAF))

Dr Chris Maske is a distinguished pathologist with extensive expertise in molecular pathology and cancer diagnostics. He has over 19 years of experience and serves as a scientific advisor at a leading biotechnology company in South Africa.

Dr Maske has contributed to significant research over the years in the field of cancer biology as well as authored several publications. His career trajectory reflects a dedication to advancing pathology and molecular diagnostics in South Africa.

(MBChB (Wits), FCSUrol (SA))

Dr. Stephen Cornish is a highly respected specialist urologist with over three decades of clinical experience and a deep passion for uro-oncology. As one of the founding urologists of the Johannesburg Academic Urology Centre (JAUC), Dr. Cornish is committed to shaping the future of urological care through education, research, and innovation.

A leading voice in prostate cancer treatment in South Africa, Dr. Cornish spearheaded the country’s first dedicated brachytherapy team for prostate cancer, bringing international techniques to local practice through advanced training in Atlanta, New York, and Paris. His extensive contributions also include the introduction of prostate artery embolisation in South Africa and leadership in multiple clinical trials focused on urological cancers and men’s health.

(BSc, MBChB, FFPath, MMed)

Dr Simon J Nayler is the Managing Partner and Consultant Histopathologist at the private laboratory of Drs Gritzman and Thatcher, a specialist cellular pathology laboratory in Johannesburg, South Africa.

He has a joint appointment at the Wits Donald Gordon Medical Centre, the private practice of the University of the Witwatersrand Medical Faculty. Previously, he was Associate Professor in the Department of Anatomical Pathology at the University of the Witwatersrand, as well as a previous appointment as president of the College of Pathologists of South Africa. Past president of the Federation of South African Societies of Pathology, and past president of the Breast Interest Group of South Africa. His interests include soft-tissue, GIT, breast, uropathology and lung pathology, particularly with regard to molecular pathology and biomarkers.

He has published more than 50 journal articles in peer reviewed publications, two books chapters one on molecular pathology. He has presented at numerous national and international meetings.

He is on numerous adboards amongst other for MSD, Novartis, Roche.

(MBChB, MMed, FAMS, FSNMMI, Hon FCMSA, Hon PhD, PhD)

Mike Sathekge is the Professor and head of Nuclear Medicine at University of Pretoria & Steve Biko Academic Hospital as well as the President & CEO of Nuclear Medicine Research Infrastructure (NuMeRI). Mike has conducted several early phase clinical studies in prostate cancer as a principal investigator and is in the forefront regarding treatment with targeted alpha therapy.

Prof Sathekge has published over 300 peer-reviewed articles, excluding abstracts and book chapters. Mike is the Editor-in-Chief of Seminars in Nuclear Medicine. He is also an Associate Editor of the European Journal of Nuclear Medicine and Molecular Imaging, Journal of Nuclear Medicine. Prof Sathekge is a member of The Lancet Oncology’s international advisory board. As the head of the IAEA Anchor Center for Rays of Hope for Cancer care, his roles includes development and implementation of radiopharmaceutical theragnostic research and capacity building. He is the Past President of the Colleges of Medicine of South Africa (CMSA), World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and past chairperson of the South African Medical Research Council (SAMRC).

He is the Chair of the Africa Health Research Institute(AHRI) and a recipient of numerous international and national merit awards. The most recent being honorary doctorate by the North West University and The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Fellow.

(BSc. Hons (Wits), MBChB (Wits), MSc in Infectious Diseases (LSHTM), FC Radiation Oncology (SA), MMed (Wits))

Dr Prinitha Pillay's sojourn into medicine did not begin in the field of oncology; instead, Dr Pillay spent the first 25 years of her medical career navigating diverse and often challenging environments that ultimately shaped her path toward oncology. Her motivation stemmed from a growing awareness: cancer is on the rise, often remains invisible until it is too late, and disproportionately affects the most vulnerable. Driven by a deep sense of purpose and the desire to effect meaningful change, she has committed herself to improving early detection and access to integrative, comprehensive cancer care—hallmarks of quality healthcare delivery.

After earning a BSc (Hons) in Molecular Biology from the University of the Witwatersrand in 1996, Dr Pillay pursued a career in medicine, qualifying as a medical doctor in 2003. Her early medical journey took her into humanitarian settings with Doctors Without Borders, where she worked over a decade in countries such as Lesotho, South and North Sudan, India, Sierra Leone, Libya, and throughout urban and rural South Africa. These experiences not only sharpened her clinical acumen under pressure but also cemented her advocacy for patient-centred care and health equity. She went on to serve as President of Doctors Without Borders in South Africa and contributed to the organisation’s global governance. In recognition of her leadership and impact, she was named one of the Top 10 Women in Health by the Mail & Guardian in 2011.

Upon returning to South Africa in 2012, Dr Pillay joined the University of the Witwatersrand as a technical specialist in HIV and TB, while also lending her voice to the Rural Health Advocacy Project to champion improved healthcare access in underserved areas. She was appointed an independent external panelist for the South African Human Rights Commission’s investigation into access to emergency medical services as a fundamental human right. During this period, she completed a Master’s degree in Infectious Diseases and Global Policy from the London School of Hygiene and Tropical Medicine.

Dr Pillay's career has consistently bridged bedside care with health systems advocacy. Her work, particularly with Doctors Without Borders, underscored the importance of bearing witness to suffering and speaking out on behalf of those without a voice. This commitment led her to specialise in Radiation Oncology, completing her Fellowship and a Master of Medicine degree focused on the sexual health and side effects experienced by women with cervical cancer following chemoradiation.